business 5 min read

The AI Slowdown Conspiracy That Could Reshape Tech Law

A new antitrust lawsuit alleges Anthropic, OpenAI, Google and SpaceXAI colluded to deliberately slow AI development. The case tests whether safety coordination and anti-competitive behavior occupy the same legal space — and which side wins will define how AI governance works for everyone.

  • Artificial Intelligence
  • Antitrust
  • OpenAI
  • Google
  • Anthropic
  • AI Safety
  • SpaceXAI

The Quiet Cartel

A lawsuit filed Friday in the Northern District of California makes a claim so unusual that it forces you to reconsider what antitrust law is actually for. The four named defendants — Anthropic, OpenAI, Google and SpaceXAI — did not price-fix. They did not divide markets. They did not exclude rivals. According to the complaint, they did something arguably more unsettling: they collectively agreed to slow down.

The coordination allegedly centered on September 12, 2026, when Anthropic CEO Dario Amodei published an essay warning that swarms of rogue AI agents could take over the internet within six months. In it, he proposed a three-point plan to pace frontier development and urged industrywide cooperation on deceleration. The same day, Sam Altman, Elon Musk and Demis Hassabis confirmed their agreement to the slowdown. The plaintiffs argue that by coordinating on pace rather than competing on it, the four labs violated antitrust law and reduced the value consumers receive from paid AI subscriptions.

The core tension in this case is not whether the slowdown happened. It is whether a slowdown is even the kind of conspiracy antitrust law was designed to address. “The antitrust laws do not permit competitors to decide among themselves that competition is too dangerous,” the plaintiffs write. That sentence carries a weight that goes far beyond the four named companies.

Antitrust doctrine has always been uncomfortable with efficiency gains that come from coordination. Price-fixing is per se illegal because it directly harms consumers. But what happens when competitors agree to restrict output — in this case, restricting the output of better models and faster capabilities — on the grounds that the product is dangerous? Is that collusion or caution? The law has no clean answer.

Amodei himself seemed to sense the trap. In his essay, he wrote that it would be helpful for the U.S. government to mediate or at least enable these cross-lab discussions and issue a narrow waiver for certain kinds of safety conversations. He did not ask the government to participate. He asked the government to step aside and authorize what amounted to a private cartel wearing a safety vest. That distinction may be the most important sentence in the entire case.

Who Pays for the Pause

The four named plaintiffs pay monthly for ChatGPT, Claude, Grok and Gemini. They are suing on behalf of a proposed nationwide class of all subscribers to those services. The allegation is straightforward: consumers who pay premium prices for rapid improvement in AI capabilities received less than they bargained for because four companies agreed to hold back.

The math here matters. If the labs truly coordinated on slowing release cycles, then subscribers across the board — not just the plaintiffs — received diminished value. Each month without a meaningful capability jump is a month of subscription fees paid for a product that could have been better but was intentionally not made better. Whether that constitutes consumer injury is exactly what the court will have to decide, and there is no precedent for it.

The China Factor

What makes this lawsuit politically explosive is the timing. The United States has been engaged in an accelerating technology competition with China, and every major lab in this suit operates under the assumption that American leadership depends on maintaining a speed advantage. The plaintiffs’ attorney, Nick Rowley, framed the stakes bluntly: “AI will quickly spin out of human control and could kill us all if we allow AI safety and protocol to be controlled by private self-serving agreements between the world’s most powerful for-profit technology companies.”

But the inverse argument is also worth considering. If the四大 AI labs are willing to coordinate a slowdown among themselves, what prevents them from coordinating a ceiling — one that effectively locks out any competitor who cannot afford to play along? The concern is not abstract. Chinese labs are already closing the gap. A legal shield that lets American companies agree to move slowly could double as a market wall.

The Government’s Role

Amodei’s proposal for a government waiver is the legal fulcrum of the entire case. If the Department of Justice or the Federal Trade Commission had formally authorized a pacing agreement, the antitrust exposure would vanish. The companies would have a shield. Without it, the question becomes whether safety concerns justify what looks indistinguishable from a horizontal restraint on innovation.

This is not the first time antitrust scholars have warned about the capture of regulatory frameworks by the industries they regulate. But this case inverts the usual dynamic. Instead of companies lobbying for looser rules, they are asking for government permission to collectively restrict their own output. The legal system has no template for that. And the political system may not want one.

What Comes Next

The defendants have not yet responded to requests for comment. That silence speaks loudly. Every major lab in this suit has publicly argued that unchecked AI development poses existential risks. Taking a public stance on the danger of uncontrolled advancement and then privately coordinating a slowdown creates a contradiction that no lawyer will easily untangle.

The case is in its earliest stages. A class certification decision could take months. The substantive antitrust questions will not be resolved until discovery — and discovery in a case about alleged coordination among the most heavily monitored companies on earth could produce documents that no one involved expects to see. Whether the lawsuit survives summary judgment will determine if the “pace-setting conspiracy” theory becomes a recognized category of antitrust harm or a cautionary footnote.

One thing is clear: whoever wins this case will set a precedent that reaches far beyond AI. If the plaintiffs prevail, the logic extends to any industry where companies coordinate on the pace of product development under the guise of safety, quality or public welfare. If the defendants prevail, the door opens for competitor coalitions to restrict output whenever they can frame it as responsible behavior. Both outcomes carry consequences that will echo through every sector that depends on software to ship.